Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Cancer News
Endoscopic eradication, recurrence comparable in BE patients with HGD, IMC
Eradication and recurrence rates of dysplasia or neoplasia are similar in patients with Barrett’s esophagus and high-grade dysplasia or intramucosal carcinoma who receive endoscopic eradication therapy, according to recent study data.
Cetuximab plus FOLFIRI only effective in RAS wild-type metastatic colorectal cancer
Molecular testing of all tumors for RAS mutations in patients with metastatic colorectal cancer should be standard practice to help guide decisions about use of anti-epidermal growth factor receptor therapy, according to a reassessment of results from the phase 3 CRYSTAL study.
Log in or Sign up for Free to view tailored content for your specialty!
Palliative care benefited patients with advanced pancreatic cancer
Patients with advanced pancreatic cancer who received palliative care underwent less aggressive end-of-life treatment, required fewer hospital admissions and survived longer than those who did not receive palliative care, according to study results.
Complete mesocolic excision for colon cancer yielded better DFS than conventional surgery
Patients with stage I to stage III colon adenocarcinoma who underwent complete mesocolic excision demonstrated longer DFS than those who underwent standard rectal surgery, according to results of a retrospective study conducted in Denmark.
PancraGen shows accuracy in predicting malignant potential of pancreatic cysts
PancraGen, an integrated molecular pathology test that combines molecular analysis with clinical test results to assess the malignant potential of pancreatic cysts, provided more accurate results compared with management recommended by current guidelines in a recent trial.
Six research developments about patients with HCC
World Cancer Day is today, February 4. Healio.com/Hepatology compiled a list of the latest studies focusing on hepatocellular carcinoma research and advancements.
Less-intensive regimen maintained efficacy, reduced toxicity in metastatic pancreatic cancer
A less-intensive first-line treatment regimen for patients with metastatic pancreatic cancer may decrease toxicity and reduce costs while maintaining efficacy, according to data from a single-institution study presented at the Gastrointestinal Cancers Symposium.
Panitumumab plus FOLFOX6 benefited patients with RAS wild-type metastatic colorectal cancer
Patients with RAS wild-type metastatic colorectal cancer treated with panitumumab plus modified FOLFOX6 chemotherapy experienced faster and more durable responses than those treated with bevacizumab plus FOLFOX6, according to phase 2 study results presented at the Gastrointestinal Cancers Symposium.
Molecular subtypes of stage III colon cancer linked to different patient outcomes
Researchers have identified subtypes of stage III colon cancer based on molecular markers associated with differences in clinical and pathological features as well as disease-free survival.
GTX effective neoadjuvant treatment in locally advanced pancreatic cancer
Patients with locally advanced, unresectable pancreatic adenocarcinoma experienced favorable survival when they received neoadjuvant gemcitabine, docetaxel and capecitabine, according to study results.
-
Headline News
Open-label placebo injection demonstrates ‘modest’ benefit in chronic back pain
October 23, 20242 min read -
Headline News
GLP-1, SGLT2 prescriptions for type 1 diabetes rising despite no regulatory approval
October 23, 20243 min read -
Headline News
CDC: 1 dead in multistate E. coli outbreak linked to McDonald’s Quarter Pounders
October 22, 20241 min read
-
Headline News
Open-label placebo injection demonstrates ‘modest’ benefit in chronic back pain
October 23, 20242 min read -
Headline News
GLP-1, SGLT2 prescriptions for type 1 diabetes rising despite no regulatory approval
October 23, 20243 min read -
Headline News
CDC: 1 dead in multistate E. coli outbreak linked to McDonald’s Quarter Pounders
October 22, 20241 min read